salicylic acid has been researched along with temozolomide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Babu, NJ; Nangia, A; Sanphui, P | 1 |
| Sarma, N | 1 |
| Andrews, DW; Bar-Ad, V; Chervoneva, I; Evans, JJ; Farrell, CJ; Glass, J; Judy, K; Liu, H; Ly, M; Martinez, N; Palmer, JD; Shi, W; Song, A; Werner-Wasik, M | 1 |
1 trial(s) available for salicylic acid and temozolomide
| Article | Year |
|---|---|
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Pilot Projects; Scalp; Temozolomide; Treatment Outcome | 2020 |
3 other study(ies) available for salicylic acid and temozolomide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Crystal engineering of stable temozolomide cocrystals.
Topics: Antineoplastic Agents, Alkylating; Crystallization; Crystallography, X-Ray; Dacarbazine; Drug Stability; Half-Life; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrolysis; Malates; Molecular Conformation; Oxalic Acid; Salicylic Acid; Succinic Acid; Tartrates; Temozolomide; Temperature | 2012 |
Stevens-Johnson Syndrome and toxic epidermal necrolysis overlap due to oral temozolomide and cranial radiotherapy.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Glioblastoma; Humans; Male; Middle Aged; Neck; Radiotherapy; Scalp; Stevens-Johnson Syndrome; Temozolomide; Thorax | 2009 |